These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 22606285

  • 1. Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.
    Vinod KY, Xie S, Psychoyos D, Hungund BL, Cooper TB, Tejani-Butt SM.
    PLoS One; 2012; 7(5):e36743. PubMed ID: 22606285
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in the Brain Endocannabinoid System in Rat Models of Depression.
    Smaga I, Jastrzębska J, Zaniewska M, Bystrowska B, Gawliński D, Faron-Górecka A, Broniowska Ż, Miszkiel J, Filip M.
    Neurotox Res; 2017 Apr; 31(3):421-435. PubMed ID: 28247204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
    Malek N, Mrugala M, Makuch W, Kolosowska N, Przewlocka B, Binkowski M, Czaja M, Morera E, Di Marzo V, Starowicz K.
    Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
    [Abstract] [Full Text] [Related]

  • 10. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 11. Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
    Cippitelli A, Astarita G, Duranti A, Caprioli G, Ubaldi M, Stopponi S, Kallupi M, Sagratini G, Rodrìguez de Fonseca F, Piomelli D, Ciccocioppo R.
    PLoS One; 2011 Jul; 6(11):e28142. PubMed ID: 22140525
    [Abstract] [Full Text] [Related]

  • 12. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
    Francavilla F, Battista N, Barbonetti A, Vassallo MR, Rapino C, Antonangelo C, Pasquariello N, Catanzaro G, Barboni B, Maccarrone M.
    Endocrinology; 2009 Oct 14; 150(10):4692-700. PubMed ID: 19608651
    [Abstract] [Full Text] [Related]

  • 14. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
    Qin M, Zeidler Z, Moulton K, Krych L, Xia Z, Smith CB.
    Behav Brain Res; 2015 Sep 15; 291():164-171. PubMed ID: 25979787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan 15; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 18. Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression.
    Hen-Shoval D, Indig-Naimer T, Moshe L, Kogan NM, Zaidan H, Gaisler-Salomon I, Okun E, Mechoulam R, Shoval G, Zalsman G, Weller A.
    J Psychiatr Res; 2024 Jul 15; 175():50-59. PubMed ID: 38704981
    [Abstract] [Full Text] [Related]

  • 19. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
    Wu HF, Lu TY, Chu MC, Chen PS, Lee CW, Lin HC.
    Neuropharmacology; 2020 Jan 01; 162():107736. PubMed ID: 31398381
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
    Smaga I, Bystrowska B, Gawliński D, Pomierny B, Stankowicz P, Filip M.
    Neurotox Res; 2014 Aug 01; 26(2):190-206. PubMed ID: 24652522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.